Skip to content

A study on the effectiveness of the cognitive behavioral therapy "Seeking Safety" in reducing trauma and addiction related symptoms in a Dutch substance-use disorder population.

A study on the effectiveness of the cognitive behavioral therapy "Seeking Safety" in reducing trauma and addiction related symptoms in a Dutch substance-use disorder population. - Effectiveness of "Seeking Safety" in a Dutch SUD-population.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39919
Enrollment
174
Registered
2011-10-18
Start date
2012-02-06
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

middelenafhankelijkheid PTSD trauma

Interventions

Control group will receive 'Treatment as usual' (TAU). De experimental group will receive twice a week sessions of Seeking Safety (the intervention) in addition to TAU. Each session lasts 75-90 minu

Sponsors

Tactus (Deventer)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Criterium A of PTSD and score >39 on SRIP - Minimum age of 18 - Speaks and understands Dutch language - DSM-IV diagnosis SUD - Given informed consent

Exclusion criteria

Exclusion criteria: - Severe psychiatric disorders (bipolar disorder, schizophrenia) that impede participation - Severe (self) destructive behavior - Insufficient level of intelligence (estimated IQ

Design outcomes

Primary

MeasureTime frame
The primary study parameter for the inpatient study is the effect of Seeking Safety on trauma related symptoms, as measured by the Self-report inventory for PTSD (SRIP). For the outpatients the main outcome measure will be substance use severity, as measured by the EuropASI.

Secondary

MeasureTime frame
Secundairy outcome measures will focus on abstinence, craving, self-efficacy, coping-skills and quality of life. Also, the influence of personality on treatment outcome will be measured, whether the effects last for a prolonged period and whether the intervention has an influence on drop-out rates.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)